Adipogenesis and lipid metabolism gene network

The Adipogenesis and lipid metabolism gene network is a complex regulatory system governing the differentiation of mesenchymal stem cells into mature adipocytes and the subsequent management of lipid stores. This network is orchestrated by a hierarchical cascade of transcription factors, most notably Peroxisome proliferator-activated receptor gamma (PPARG) and members of the CCAAT/enhancer-binding protein (C/EBP) family (Farmer, 2006, Nature Reviews Molecular Cell Biology). These factors control the expression of genes involved in fatty acid uptake, triglyceride synthesis, and lipolysis, thereby maintaining systemic energy homeostasis (Rosen & Spiegelman, 2014, Nature). Dysregulation of this network is a primary driver of metabolic disorders, including obesity, insulin resistance, and non-alcoholic fatty liver disease (Lefterova & Lazar, 2009, Trends in Endocrinology & Metabolism). Pharmacological intervention typically focuses on specific nodes within the network; for instance, thiazolidinediones act as agonists for PPARG to enhance insulin sensitivity, though they often carry side effects like weight gain and fluid retention (Yau et al., 2013, Cochrane Database of Systematic Reviews). Understanding the integrated dynamics of this network is crucial for developing multi-target or pathway-specific therapies for metabolic syndrome.

Other names

Adipogenic regulatory networkLipid metabolic pathwayAdipocyte differentiation programAdipogenesis signaling pathway

Modulation of key transcriptional regulators such as PPAR-gamma and C/EBPs, or inhibition of rate-limiting enzymes like HMG-CoA reductase and Fatty Acid Synthase, to alter lipid storage, adipocyte maturation, and systemic metabolic flux.